Is EYEG stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, EyeGate Pharmaceuticals pays dividends. Last time was Wednesday 6th of November 2024 where the investors holding the stock on Friday 1st of November 2024 were paid $0.15150 per share. Over the last 11 times between 2023 and 2024, EyeGate Pharmaceuticals has paid $1.5997 with an average of $0.15 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for EyeGate Pharmaceuticals 10 years ago, but if you had invested on Friday 31st of July 2015 when the price was $7.15, you would have made a profit of $28.59 per share or 399.86%
No, the average daily trading liquidity for EyeGate Pharmaceuticals is $24 423 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
EyeGate Pharmaceuticals has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 12.67, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for EyeGate Pharmaceuticals to be low [0.4 out of 1]